STATE OF WISCONSIN INVESTMENT BOARD - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 145 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$400,703
+12.5%
75,462
+101.9%
0.00%0.0%
Q2 2023$356,136
-17.8%
37,370
-5.1%
0.00%0.0%
Q1 2023$433,081
-26.2%
39,371
-0.7%
0.00%
-50.0%
Q4 2022$586,894
-27.0%
39,655
-5.8%
0.00%
-33.3%
Q3 2022$804,000
+33.8%
42,081
+49.3%
0.00%
+50.0%
Q2 2022$601,000
+23.4%
28,192
+11.4%
0.00%
+100.0%
Q1 2022$487,000
-7.2%
25,3000.0%0.00%0.0%
Q4 2021$525,000
-13.1%
25,3000.0%0.00%0.0%
Q3 2021$604,000
-12.5%
25,3000.0%0.00%0.0%
Q2 2021$690,000
-5.7%
25,3000.0%0.00%
-50.0%
Q1 2021$732,000
+2.8%
25,3000.0%0.00%0.0%
Q4 2020$712,000
+51.8%
25,300
+58.1%
0.00%
+100.0%
Q3 2020$469,000
-3.1%
16,0000.0%0.00%0.0%
Q2 2020$484,000
+1.5%
16,0000.0%0.00%
-50.0%
Q1 2020$477,00016,0000.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$165,956,00012.78%
Bain Capital Life Sciences Investors, LLC 3,000,000$57,330,0006.84%
Pivotal bioVenture Partners Investment Advisor LLC 569,041$10,874,0003.97%
Logos Global Management LP 1,525,000$29,143,0003.58%
1492 Capital Management LLC 178,320$3,408,0002.45%
Cormorant Asset Management, LP 1,000,000$19,110,0001.34%
MPM BioImpact LLC 257,185$4,915,0001.16%
Orbimed Advisors 2,800,000$53,508,0000.99%
SECTORAL ASSET MANAGEMENT INC 220,985$4,223,0000.83%
Rubric Capital Management LP 472,047$9,021,0000.45%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders